You searched for metabolic diseases - Page 12 of 64

News and Trends 18 Jan 2017

Evotec launches New Biotech to tackle the Most Deadly Diseases

…in the new company, which will develop first-in-class therapeutics for fibrotic diseases. Fibrotic diseases, which include chronic kidney disease, liver fibrosis, systemic sclerosis, pulmonary fibrosis, myocardial infarction, stroke and cancer,…

January 18, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

orphazyme niemann pick type c disease rare metabolic disease molecules

News and Trends 30 Jan 2019

Danish Biotech’s Drug for Rare Metabolic Disease Aces Clinical Trial

A drug, developed by the Danish biotech Orphazyme for a rare metabolic disease, has shown promising results in a phase II/III trial, reducing the disease’s progression by 74%. The 50…

January 30, 2019 - 3 minutesmins - By Jonathan Smith

Best in Biotech 21 Nov 2024

Eight areas where gene therapy shines

…eye diseases Gene therapy offers an interesting application in addressing ophthalmological disorders, especially inherited retinal diseases (IRDs) that cause gradual vision loss. The idea is to deliver functional genes directly…

November 21, 2024 - 12 minutesmins - By Jules Adam

News and Trends 12 Dec 2024

Top biotech deals of November 2024

…earn up to $745 million in upfront and milestone payments. Finally, pharma giant Novo Nordisk continues its streak with the metabolic and heart diseases therapeutic field. It has tapped Ascendis…

December 12, 2024 - 9 minutesmins - By Roohi Mariam Peter

numab intarcia antibodies implantable drug delivery

News and Trends 6 Jun 2016

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

…next generation of Intarcia’s implantable therapies, beyond ITCA 650. Intarcia’s subcutaneous implant for drug delivery (Credit: Intarcia) The developed antibodies are targeting metabolic, inflammatory and autoimmune diseases – key markets…

June 6, 2016 - 2 minutesmins - By Denise Neves Gameiro

In Depth 30 Dec 2020

A Look Back at the Past Decade of European Biotech

…this field seek to tackle aging-related diseases. Why is this so important? According to Alexandra Bause, a wide range of diseases can be attributed to aging. “In our 20s, 30s,…

December 30, 2020 - 15 minutesmins - By Karen O’Hanlon Cohrt

In Depth 26 Sep 2024

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

…SPECT to visualize biological processes within the body. These tracers often target specific biomarkers or metabolic pathways associated with diseases, especially cancer. Examples of commercially available radiotracers include fluorodeoxyglucose (FDG),…

September 26, 2024 - 14 minutesmins - By Jules Adam

vienna biotech valneva sanochemia aop pharma

News and Trends 12 Sep 2016

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

…now started a Phase I trial. AFFiRiS is also developing novel vaccines, as immunotherapies to prevent cardiometabolic and neurodegenerative diseases chronic diseases. It was founded in 2003, and has recently…

September 12, 2016 - 6 minutesmins - By Denise Neves Gameiro

News and Trends 31 Aug 2022

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

…a variety of neuroinflammation-driven diseases, the low molecular weight dextran sulfate compound both mobilized and modulated naturally occurring tissue repair mechanisms and restored cellular homeostasis and function by releasing heparin-binding…

August 31, 2022 - 2 minutesmins - By Jim Cornall

In Depth 3 Nov 2022

What’s on the horizon for gene editing-based therapies?

…adding that future pioneers could “completely upend the way we are doing things.” Picture/Shutterstock From rare diseases to bigger indications One reason that gene editing companies treat rare diseases is…

November 3, 2022 - 8 minutesmins - By Jonathan Smith

News and Trends 8 Jun 2023

Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases

…worldwide license to develop, manufacture and commercialize KT430 to treat X-linked myotubular myopathy (XLMTM). There are a large number of genetically defined and complex muscle and heart diseases that cannot…

June 8, 2023 - 4 minutesmins - By Jim Cornall

News and Trends 8 Mar 2023

Affibody and Chiesi Group to develop treatments for respiratory diseases

Affibody AB and Chiesi Farmaceutici S.p.A have announced a collaboration and licensing agreement to develop and commercialize innovative treatments for respiratory diseases using Affibody’s proprietary technology. Under the terms of…

March 8, 2023 - 3 minutesmins - By Jim Cornall

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Evotec launches New Biotech to tackle the Most Deadly Diseases

Danish Biotech’s Drug for Rare Metabolic Disease Aces Clinical Trial

Eight areas where gene therapy shines

Top biotech deals of November 2024

Swiss-US Implant could make taking pills obsolete in Autoimmune Diseases

A Look Back at the Past Decade of European Biotech

The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond

Grüßgott, get to Meet 9 exciting Biotechs from Vienna

Research shows TikoMed’s ILB has the potential to treat neurodegenerative diseases including ALS

What’s on the horizon for gene editing-based therapies?

Kate Therapeutics launches with $51M to develop genetic medicines for muscle and heart diseases

Affibody and Chiesi Group to develop treatments for respiratory diseases

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!